F/M Emerald Life Sciences Innovation ETF (LFSC)
NASDAQ: LFSC · Real-Time Price · USD
43.40
-0.06 (-0.14%)
At close: Oct 2, 2026, 4:00 PM EDT
43.28
-0.12 (-0.28%)
After-hours: Oct 2, 2026, 7:30 PM EDT
LFSC Holdings Information
LFSC is an equity ETF with a total of 42 individual holdings. The top holdings are Corcept Therapeutics stock at 7.13%, Travere Therapeutics at 6.61%, LivaNova at 6.52%, Cogent Biosciences at 6.17%, and Spyre Therapeutics at 5.33%.
Total Holdings
42
Top 10 Percentage
52.53%
Asset Class
Equity
ETF Category
Health
Assets
120.65M
PE Ratio
n/a
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | CORT | Corcept Therapeutics Incorporated | 7.13% |
| 2 | TVTX | Travere Therapeutics, Inc. | 6.61% |
| 3 | LIVN | LivaNova PLC | 6.52% |
| 4 | COGT | Cogent Biosciences, Inc. | 6.17% |
| 5 | SYRE | Spyre Therapeutics, Inc. | 5.33% |
| 6 | BLLN | BillionToOne, Inc. | 4.74% |
| 7 | REPL | Replimune Group, Inc. | 4.55% |
| 8 | GH | Guardant Health, Inc. | 4.42% |
| 9 | MANE | Veradermics, Incorporated | 3.60% |
| 10 | AXSM | Axsome Therapeutics, Inc. | 3.46% |
| 11 | MIRM | Mirum Pharmaceuticals, Inc. | 3.45% |
| 12 | CYTK | Cytokinetics, Incorporated | 3.41% |
| 13 | TMDX | TransMedics Group, Inc. | 3.27% |
| 14 | TWST | Twist Bioscience Corporation | 2.90% |
| 15 | SVRA | Savara Inc. | 2.83% |
| 16 | UTHR | United Therapeutics Corporation | 2.69% |
| 17 | ICUI | ICU Medical, Inc. | 2.65% |
| 18 | DNTH | Dianthus Therapeutics, Inc. | 2.38% |
| 19 | TRVI | Trevi Therapeutics, Inc. | 2.33% |
| 20 | VRDN | Viridian Therapeutics, Inc. | 2.18% |
| 21 | NKTR | Nektar Therapeutics | 2.06% |
| 22 | PVLA | Palvella Therapeutics, Inc. | 1.98% |
| 23 | CBLL | CeriBell, Inc. | 1.80% |
| 24 | CRVS | Corvus Pharmaceuticals, Inc. | 1.56% |
| 25 | HNGE | Hinge Health, Inc. | 1.49% |
As of Oct 1, 2026